Beyond Relaxation: Clinical measurements, heart rate variability, and the pathway toward scientific validation
Report by Lennard M. Goetze, Ed.D. & Leslie Valle, MD | November 2026
The project combines a four-week exploratory pilot conducted by the Brainwave Wellness Institute and Santa Barbara Longevity Center with clinical performance assessments by Leslie Valle, MD, and research interpretation involving the Institute for Progressive Health Sciences (IPHS). A companion research review also credits Roberta (Bobbi) Kline, MD, Lennard Goetze, Ed.D., and Daniel Root, and acknowledges Relax Saunas and Thomas Vallee. These contributions should not be confused with an independently verified clinical efficacy trial.
How the Four-Week Pilot Was Conducted: Ten adults, eight women and two men aged 30–61, completed three far-infrared sauna sessions weekly for four weeks. Each session lasted approximately 20–30 minutes at 140°F. Four participants used a recumbent unit and six used a seated unit. Investigators recorded session-level vital signs before exposure and about ten minutes after exposure. The pilot also included exploratory baseline and follow-up assessments using heart rate variability (HRV), bioimpedance, and thyroid ultrasonography. The study was single-arm, without a control group, and its results were summarized descriptively rather than tested for statistical significance.
What the Cardiovascular Measurements Showed: Across 120 paired session observations, systolic blood
pressure was lower after 110 exposures and diastolic pressure was lower after
100. Average declines were approximately 6 mmHg systolic and 7 mmHg diastolic.
Heart rate remained elevated in all 120 recovery measurements, averaging
approximately 16 beats per minute above baseline. Oxygen saturation and
respiratory rate were broadly stable. These findings document a consistent
early-recovery cardiovascular response to thermal exposure, not evidence that
the sauna treats hypertension or provides the same physiological benefits as
exercise.
The response is physiologically plausible: passive heat promotes skin blood-flow redistribution and thermoregulatory demands, while heart rate and vascular dynamics adjust. Importantly, measurements obtained ten minutes after treatment capture recovery, not necessarily the peak response during heat exposure. Future investigations should measure both phases and standardize hydration, posture, room conditions, and timing.
Why Dr. Valle-Montoya Introduced Heart Rate Variability: Dr. Leslie Valle-Montoya’s contribution is particularly important because she introduced comparative HRV assessment as a means of examining autonomic regulation. HRV describes the variation in time between successive heartbeats. Unlike pulse rate alone, it provides a window into how cardiac rhythm responds to breathing, activity, and autonomic influences. Used carefully, HRV can help researchers ask whether a physiological state differs before and after an intervention, and whether any change is reproducible over time.
In an illustrated August 24, 2026 case comparison, a
participant underwent approximately four-minute HRV recordings before and after
a reported 30-minute sauna session. Total spectral power increased from 735 to
1,042, while the device stress index fell from 151 to 112. The
software-generated energy-resources score rose from 105 to 137, and its complex
state index rose from 34% to 46%. The total-power value remained below the
device’s printed reference interval, while the stress index remained above its
reference interval. The recording conditions and different artifact-filter
settings also limit strict comparability.
These measurements are valuable as observations, but the distinction between conventional HRV quantities and proprietary software scores is crucial. A device-derived “neurohumoral” score is not a direct hormone assay; a “psychoemotional” score is not a clinical mental-health assessment; and a model-generated biological-age estimate does not demonstrate reversal of aging. Likewise, HRV-derived graphics labeled as brainwave activity cannot replace electroencephalography.
What Additional Comparative HRV Records Suggest- A supplementary internal report summarized paired HRV records for three participants from the ten-volunteer review. Their total spectral power increased by approximately 94.8%, 47.3%, and 205.8%, respectively; their device stress indices declined by approximately 33.7%, 37.5%, and 58.9%. These are within-person differences recorded on separate dates, not estimated treatment effects. Several other indices were mixed or unchanged, including energy-balance and neurohumoral measures in some participants. Because the supplementary report is explicitly marked “for internal use only,” its figures require publication authorization before external release.
The central scientific contribution is therefore methodological: Dr. Valle-Montoya has shown how paired autonomic recordings can generate testable endpoints for future study. To establish clinical relevance, investigators will need standardized recording duration, controlled breathing and posture, consistent artifact correction, prespecified primary outcomes, raw interval data, and comparison groups.
"OligoScan(TM)" and the Detoxification Question: The exploratory program also employed OligoScan to compare device-reported mineral and potentially toxic-metal readings over repeated sauna use. Some longitudinal readings, including aluminum and mercury, reportedly declined. Such observations cannot establish that the sauna removed metals, identify their route of elimination, or quantify toxicant clearance. Those questions require validated blood, urine, and potentially sweat assays, careful exposure histories, and appropriate controls. Sweating is a measurable thermoregulatory process; “detoxification” is a separate scientific claim.
Why Validation Is the Decisive Next Step- A well-designed validation program should distinguish three
questions: Does sauna exposure produce a physiological response? Is that
response repeatable and distinguishable from normal variation or confounding?
Does it produce a durable, meaningful health outcome? The current pilot provides
evidence relevant principally to the first question, with useful leads for the
second. It does not establish the third.
Future phases could incorporate a comparison group,
prespecified HRV metrics, continuous heart-rate monitoring, standardized
blood-pressure measurement, hydration and medication documentation, validated
stress and sleep questionnaires, and longer follow-up. Additional laboratory
biomarkers—such as inflammatory markers—could be considered with careful
attention to fluid shifts and sampling time. Investigators should also disclose
financial relationships, confirm research ethics oversight, and make the
measurement protocol sufficiently transparent for independent replication.
The Significance for Health Technology
The Relax Sauna performance review demonstrates a practical
way to move wellness technology into scientific inquiry. Its strongest evidence
concerns repeatable cardiovascular changes during early recovery; its
autonomic, body-composition, imaging, and toxicology observations remain
exploratory. Dr. Valle-Montoya’s HRV work contributes a measurable framework
for examining regulation and recovery, while the participating institutions
provide a setting for multidisciplinary interpretation and future study design.
The significance of this investigation is not a declaration
that a sauna has been clinically validated. It is the demonstration that an
intervention can be studied systematically, that promising signals can be
separated from unsupported claims, and that more rigorous questions can now be
formulated. In responsible health-technology evaluation, the path from
observation to validation is itself an important achievement.
Who Is Dr. Leslie Valle?
Leslie Valle, MD, is the investigative examiner and clinical performance tester identified in the Relax Far-Infrared Sauna assessment reports. Her contribution has centered on the application and interpretation of heart rate variability (HRV) and other comparative physiological measurements to investigate autonomic regulation, stress-related device indices, and responses to passive heat. Through before-and-after assessments, she has helped establish a quantitative record of changes that can inform future protocols. Her work in this project is best understood as exploratory clinical investigation: the recorded shifts generate hypotheses, while independent validation is still required before clinical benefits can be established.CONTRIBUTING INSTITUTIONS
The Brainwave Wellness Institute is identified in the
project materials as a nonprofit wellness-research organization and a central
contributor to the far-infrared sauna performance investigation. Working with
Santa Barbara Longevity Center, it conducted a four-week pilot examining vital
signs, autonomic measures, body-composition indicators, and selected imaging
observations. Its approach emphasizes the value of moving beyond subjective
wellness experience toward documented physiological response, repeated measurements,
and progressively stronger study designs. The Institute’s pilot findings are
preliminary and should not be represented as definitive proof of efficacy.
The Institute for Progressive Health Sciences (IPHS), founded and directed by Lennard M. Goetze, Ed.D., is a multidisciplinary health-sciences initiative focused on evaluating emerging medical and wellness technologies and communicating scientific findings responsibly. Its fields of inquiry include preventive and predictive health, medical imaging, cancer survivorship, integrative and functional health, neuroscience, rehabilitation, and healthy aging. In the Relax Sauna project, IPHS contributed research documentation, editorial synthesis, and interpretation of the available clinical performance data, helping frame preliminary observations as questions for structured validation and independent investigation.






